Fx-1006A is a small molecule compound with the potential to treat genetic disorders, such as familial amyloid cardiomyopathy (FAC) and familial amyloid polyneuropathy (FAP).
Investigated for use/treatment in amyloidosis.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.